Showing results (81-90 of 756) with videos related to

Sort By:
Pageof 76
The Lancet. Gastroenterology & Hepatology|July 23, 2021
Effect of a deep learning-based system on the miss rate of gastric neoplasms during upper gastrointestinal endoscopy: a single-centre, tandem, randomised controlled trialLianlian Wu, Renduo Shang, Prateek Sharma, et al.
The Lancet. Gastroenterology & Hepatology|May 13, 2022
Serrated polyp detection and risk of interval post-colonoscopy colorectal cancer: a population-based studyDavid E F W M van Toledo, Joep E G IJspeert, Patrick M M Bossuyt, et al.
The Lancet. Gastroenterology & Hepatology|May 19, 2022
Transjugular intrahepatic portosystemic shunt with or without gastro-oesophageal variceal embolisation for the prevention of variceal rebleeding: a randomised controlled trialYong Lv, Hui Chen, Bohan Luo, et al.
The Lancet. Gastroenterology & Hepatology|September 13, 2019
Precision medicine in pancreatic cancer: treating every patient as an exceptionBrian Herbst, Lei Zheng
The Lancet. Gastroenterology & Hepatology|September 4, 2019
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trialNalinie Joharatnam-Hogan, Fay Cafferty, Richard Hubner, et al.
The Lancet. Gastroenterology & Hepatology|February 14, 2021
Prevention and treatment of nutritional complications after bariatric surgeryAlexandre Nuzzo, Sebastien Czernichow, Alexandre Hertig, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2021
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control studyShaji Sebastian, Gareth J Walker, Nicholas A Kennedy, et al.
The Lancet. Gastroenterology & Hepatology|December 6, 2016
Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept studyGeorge Lau, Yves Benhamou, Guofeng Chen, et al.
The Lancet. Gastroenterology & Hepatology|November 26, 2018
Place of death and factors associated with hospital death in patients who have died from liver disease in England: a national population-based studyJen-Kuei Peng, Irene J Higginson, Wei Gao
The Lancet. Gastroenterology & Hepatology|February 24, 2019
Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trialsMaria Buti, David K Wong, Edward Gane, et al.
Pageof 76